Ardent Health: former CEO's separation recharacterized as termination for cause

What happened Ardent Health filed an 8-K reporting that Martin J. Bonick’s employment as President and Chief Executive Officer and his service on the board ended effective Jun 2, 2026. The filing states that Mr. Bonick and AHS Management Company, Inc. entered into a Separation Agreement dated Jun 26, 2026 providing severance consistent with a termination without "Cause". On Oct 19, 2026, after notice to Mr. Bonick and a hearing, the board determined that facts discovered after the Separation Date would have given the company grounds to terminate his employment for "Cause" as of Jun 2, 2026, and the company recharacterized the separation as a termination for "Cause".

Key details

• Employment ended effective Jun 2, 2026; Separation Agreement dated Jun 26, 2026.
• Board determination made on Oct 19, 2026 after notice and a hearing.
• Company will discontinue remaining severance payments, including approximately $4,500,000 of unpaid cash severance, and all outstanding unvested performance-based restricted stock units (PRSUs) will be cancelled or forfeited.
• The company stated that none of its financial statements or previously disclosed financial results require revision as a result of this action.

Why it may matter The filing reports Item 5.02 (departure of directors or certain officers), which covers the company’s report of an officer’s separation, the board’s recharacterization of that separation as a termination for "Cause", related severance treatment, and equity forfeiture. A filing does not show why the insider traded or why the company acted.